News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016
News Features Brooding Over Brexit: Cardiologists Voice Uncertainty About Effects on Collaboration, Research Funding Yael L. Maxwell June 29, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Daily News For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs July 25, 2013
News Daily News En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida July 25, 2013
News Conference News PARTNER: TAVI Cost Effective Compared With Standard Care Jason Kahn April 03, 2011